Literature DB >> 23596589

Management of vaccine safety in Korea.

Young June Choe1, Geun-Ryang Bae.   

Abstract

Although vaccination is regarded as one of the most effective public health measure to prevent and control infectious diseases, no vaccine is perfectly safe. Therefore, safety management is an essential component in running National Immunization Program. Here, we review the current issues and suggest future perspectives of Korean vaccine safety management system.

Entities:  

Keywords:  Adverse events following immunization; Drug toxicity; Vaccines

Year:  2013        PMID: 23596589      PMCID: PMC3623500          DOI: 10.7774/cevr.2013.2.1.40

Source DB:  PubMed          Journal:  Clin Exp Vaccine Res        ISSN: 2287-3651


  17 in total

1.  Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Advisory Committee on Causality Assessment.

Authors:  J P Collet; N MacDonald; N Cashman; R Pless
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

2.  The National Vaccine Injury Compensation Program.

Authors:  Katherine M Cook; Geoffrey Evans
Journal:  Pediatrics       Date:  2011-04-18       Impact factor: 7.124

Review 3.  Epidemiologic methods in immunization programs.

Authors:  R T Chen; W A Orenstein
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

4.  Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis.

Authors:  A Shefer; L Dales; M Nelson; B Werner; R Baron; R Jackson
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

5.  Local skin complications of BCG vaccination.

Authors:  J Verbov
Journal:  Practitioner       Date:  1984-11

Review 6.  Hypersensitivity reactions to vaccine constituents: a case series and review of the literature.

Authors:  Jonathan S Leventhal; Emily M Berger; Jeremy A Brauer; David E Cohen
Journal:  Dermatitis       Date:  2012 May-Jun       Impact factor: 4.845

Review 7.  Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations.

Authors:  Kevin Forsyth; Masaaki Nagai; Alejandro Lepetic; Evelinda Trindade
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

8.  Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin.

Authors:  J M Kelso; R T Jones; J W Yunginger
Journal:  J Allergy Clin Immunol       Date:  1993-04       Impact factor: 10.793

Review 9.  Control of pertussis in the world.

Authors:  A Galazka
Journal:  World Health Stat Q       Date:  1992

10.  Reactions of Norwegian children with severe egg allergy to an egg-containing influenza A (H1N1) vaccine: a retrospective audit.

Authors:  Bård Anders Forsdahl
Journal:  BMJ Open       Date:  2012-01-05       Impact factor: 2.692

View more
  4 in total

1.  Machine Learning Approach for Active Vaccine Safety Monitoring.

Authors:  Yujeong Kim; Jong Hwan Jang; Namgi Park; Na Young Jeong; Eunsun Lim; Soyun Kim; Nam Kyong Choi; Dukyong Yoon
Journal:  J Korean Med Sci       Date:  2021-08-09       Impact factor: 2.153

2.  Surveillance and compensation claims for adverse events following immunization from 2011 to 2016 in the Republic of Korea.

Authors:  Min-Kyung Kim; Yeon Kyeong Lee; Tae Eun Kim; Insik Kong; Hyeon-Jong Yang; Eun Sook Suh
Journal:  Clin Exp Vaccine Res       Date:  2017-07-26

3.  Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005-2017.

Authors:  Dongwon Yoon; Ju Hwan Kim; Hyesung Lee; Ju Young Shin
Journal:  Yonsei Med J       Date:  2020-07       Impact factor: 2.759

4.  Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015.

Authors:  Young June Choe; Emmanuel Vidor; Christine Manson
Journal:  Infect Dis Ther       Date:  2022-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.